financetom
Business
financetom
/
Business
/
SpiceJet misses street expectations as it posts Rs 461 crore loss in Q2
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
SpiceJet misses street expectations as it posts Rs 461 crore loss in Q2
Nov 13, 2019 8:56 AM

Low-cost carrier SpiceJet on Wednesday reported a net loss of Rs 461.2 crore versus a loss of Rs 382.7 crore compared year on year.

The loss is worse than what the street had expected. An Edelweiss report had forecast a loss of Rs 312 crore.

The airline reported a 51.8 percent hike in revenue at Rs 2,848 crore versus Rs 1,876.6 crore, compared for the same period last year.

In a release to exchanges, SpiceJet has said that the loss in the second quarter is on account of inflated costs with respect to MAX grounding and a seasonally weak quarter.

The airline has further said that the likely return to service of the MAX in January 2020 will boost their balance sheets.

"Likely return to service of the MAX in January 2020, as indicated by

Boeing, to be a big boost that will add new fuel and operationally efficient

aircraft in Q4 FY2020," the statement reads.

The company plans to enhance passenger capacity by inducting aircraft on short term leases in the ongoing winter schedule. The current fleet size as of September 30 is 113.

It is not all glum reading. The airline has registered a record domestic load factor of 92.6 percent and claims to have clocked 90 percent plus PLF (passenger load factor) for a record 53 successive months.

Shares of the airline on Wednesday declined nearly 2 percent to close at Rs 114.95 apiece on the BSE.

First Published:Nov 13, 2019 5:56 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved